CrackitToday App

Tirzepatide : Weight Loss Drug

Tirzepatide : Weight Loss Drug

India is set to approve the weight-loss drug tirzepatide marking a significant advancement in obesity treatment.

  • This follows global trends where drugs like semaglutide (Ozempic and Wegovy) have shown dramatic weight loss effects.
  • Tirzepatide, originally approved for diabetes, also induces weight loss by boosting hormones GLP-1 and GIP, which promote satiety and manage glucose levels.
  • Clinical trials have demonstrated substantial weight loss with tirzepatide, with participants losing up to 20.9% of their body weight.
  • However, ongoing use is necessary to maintain these results, as stopping the medication leads to weight regain.
    Side effects include nausea, vomiting, and risk of thyroid tumours.